Mr. Speaker, there have been many negotiations and we had a strong team of negotiators. They have illustrated that the price of prescription drugs would not be increased. This would actually have a positive benefit, because we would have more access to markets.
The statement that the hon. member just made is inaccurate. The cost of prescription drugs would not increase under this new NAFTA.